What is it about?
Atherosclerotic and thrombotic disease associated with human immunodeficiency virus (HIV) infection has been studied, showing that HIV patients have 50% increased cardiovascular risk compared with the world population, contemporary, despite efforts, we cannot eradicate HIV and most patients will require lifelong treatment .
Featured Image
Why is it important?
Atherosclerotic and thrombotic disease associated with human immunodeficiency virus (HIV) infection has been studied, showing that HIV patients have 50% increased cardiovascular risk compared with the world population, contemporary, despite efforts, we cannot eradicate HIV and most patients will require lifelong treatment [1,2].
Perspectives
Besides the varied form of presentation and the small number of patients there are currently no long-term follow-up of those patients, but we can affirm that there is an extensive documentation of the association between vascular disease and HIV infection, however the applicability of these resources in this group of patients, which differs from classic atherosclerotic plaque, requires more time observation, although already supported by the literature we can consider the endovascular procedures an option for these patients.
Professor Paulo Eduardo Ocke Reis
Universidade Federal Fluminense
Read the Original
This page is a summary of: Endovascular Procedures to treat HIV patients with associated Arterial Disease, Angiology Open Access, January 2017, OMICS Publishing Group,
DOI: 10.4172/2329-9495.1000e117.
You can read the full text:
Contributors
The following have contributed to this page
